Global MEMS For Therapeutic Market Overview

Global MEMS For Therapeutic Market was valued at USD 7.39 Billion in 2021 and is expected to reach USD 17.07 Billion by the year 2028, at a CAGR of 12.7%.

The origins of MEMS technologies can be traced back to 1954 when Smith published a paper entitled "Piezoresistive effects in silicon and germanium" in the international journal "Physical Review". Since then, advancements in technologies opened doors for the development of MEMS for healthcare needs. In medicine, therapeutics is related to the care of the patient and includes preventing as well as managing disease or disease-specific problems. Microtechnology and MEMS (microelectromechanical systems) have transformed and in the upcoming future will continue to revolutionize therapeutic medicine as more technological advances are made. Many companies have launched micro-sized devices that have sensors and are utilized to monitor pressure, temperature, and oxygenation level. Several companies have started working on new devices to change the therapeutics procedure. A narrow therapeutic window is the main challenge to the conventional drug release system and this can be overcome by employing MEMS therapeutic solutions. For instance, several studies are being carried out to check the potential of the MEMS sensors in continuous glucose monitoring systems. The growing awareness about the benefits of MEMS in therapeutics is propelling the expansion of MEMS for the therapeutics market over the forecast period.

Market Dynamics And Key Factors of MEMS For Therapeutic Market

Drivers:

Increasing applications of MEMS devices in healthcare and the growth in the personal healthcare market including wireless implants are driving the expansion of the market during the forecast period. The rise in the awareness and affordability of healthcare services has further propelled the demand for MEMS devices in the medical industry. Early detection and treatment of disease are paramount for improving human health and wellness. MEMS devices enable new opportunities for the quick, cost-effective, and precise detection of abnormal biological states that can detect the early onset of disease. MEMS devices can function at a scale more sensitive to numerous biological processes.

MEMS for therapeutics are mostly sensors that can be employed inside or on the human body to monitor the functioning of vital organs. Implantable biomedical MEMS devices are incorporated to detect the presence of disease-specific biomarkers. On the body, devices gather and process information. Combination devices detect, monitor, and manage the disease. Bio-sensing is a vast concept that includes disease diagnosis to provide physicians with valuable data, regarding blood oxygen levels, and intraocular or aortic pressure. MEMS for therapeutic sensors are lab on chip concept. Moreover, MEMS medical sensors have given rise to microfluidics-it is a study of the behavior of fluids through micro-channels, and the technology of manufacturing microminiaturized devices to detect the presence of harmful microorganisms.

The rise in the number of individuals suffering from diabetes, hypertension, depression, and other chronic illness has boosted the growth of the MEMS for the therapeutic market. Usage of MEMS for monitoring services has given rise to a continuous monitoring system such as glucose monitoring systems. For instance, an implanted glucose-sensing element detects an increase in glucose levels, this information is sent to an external insulin pump which then injects insulin to counteract the increased glucose levels. Wireless implantable continuous glucose monitoring system employs an array of platinum electrodes with corresponding silver/silver chloride reference electrodes to monitor the two-step enzymatic reaction of glucose oxidase and catalase which is compared to an oxygen-sensing reference.

Restraints:

High costs involved during the research and development of new MEMS devices for therapeutic usage, and the expensive upfront cost required for the fabrication of cleanrooms and foundry facilities are the vital factors that will hamper the growth of the MEMS for the therapeutic market over the forecast period. Moreover, the cost of a single unit is very high and if they are utilized for niche applications, the desired outcome can't be achieved. Developing countries lack the expertise and superior infrastructure to support the growth of the MEMS for the therapeutic market. Government regulations and the non-acceptance of new technologies in diagnostics pose restraining factors for MEMS for the therapeutic market.

Opportunities:

The constant demand for improved efficacy, safety, and functionality in in-vivo therapeutics opens up endless opportunities for players involved in MEMS for the therapeutic market. The rise in the number of research activities to improve the functionality of MEMS devices by enhancing sensitivity, specificity, and the integration of these devices with biological processes will bolster medical science with novel MEMS-based diagnostics and therapeutics. New technological advancement in MEMS devices enables the creation and integration of MEMS devices into Microfluidic systems and cell sorting devices. Separation methods offered by microfluidic system technology can potentially manipulate individual cells, reduce reagent costs, enable high-volume experiments, and separate and isolate areas of micro structuring of samples such as blood and other species, allowing for faster reaction work than traditional modeling methods. Furthermore, the growing prevalence of chronic conditions worldwide and the growing demand for MEMS-based therapeutic procedures will create profitable opportunities for organizations in the MEMS for the therapeutic market. 

Challenges:

The introduction of new materials with novel features to complement current medical implants requires careful analysis of the impact of the materials on cellular toxicity, mutagenicity, reactivity, and stability. Moreover, replacing defective biological systems with implanted artificial equivalents must function with the same biological constraints, have consistent reliability, and ultimately show the promise of enhancing human health. Stringent regulatory guidelines imposed by government authorities and the lack of funds for setting up manufacturing utilities in the developing economies pose a major challenge for MEMS for the therapeutics market.

Market Segmentation

Segmentation Analysis of MEMS For Therapeutic Market:

Depending on product type, the microfluidics segment is forecasted to have the highest share of the MEMS therapeutic market attributed to the development of microfluidic devices that are small in size and are termed as "lab on chip" systems. Microfluidics devices include microneedles, microchannels, and micro-pumps. Microneedles have several therapeutic applications. They can be employed for transdermal fluid sampling, delivery vaccines, and drug delivery. The microneedles can be utilized along with microchannels, micro-pumps, and sensors. For instance, hollow microneedles can be utilized to extract fluid from beneath the skin in a minimally invasive sampling process. The extracted fluid travels along the length of the needle and eventually into microchannels, from where it is pumped onto the active sensor surface. The sensor then detects the presence of a particular biomarker in the sample fluid. Such a process can also be incorporated in continuous glucose monitoring systems thus, consolidating the growth of the segment over the projected period.

Depending on end-users, the home healthcare segment is projected to dominate the MEMS for therapeutic market in the forecast period. The rise in the number of individuals suffering from diabetes, cardiovascular, and hypertension is the main cause supporting the usage of MEMS devices in the home healthcare segment. MEMS technology has revolutionized diagnosing and therapeutic procedures of several diseases. The advent of microfluidics has created vast opportunities for novel detecting procedures that can help in the management and treatment of several diseases. Home healthcare services reduce the cost required for hospital visits and can give the point of care healthcare services. For instance, the continuous glucose monitoring system detects the drop in the level of insulin and stimulates the pump to inject insulin into the bloodstream. In addition, heart failure is one of the leading causes of mortality, MEMS pressure sensor can detect the changes in the blood pressure and can notify the user way before any potential risk event. Therefore, the rise in the number of wearable devices is stimulating the development of the home healthcare segment.

Regional Analysis of MEMS For Therapeutic Market:

The North American region is anticipated to have the highest share of MEMS for the therapeutic market throughout the forecast. The early adoption of emerging technologies and the presence of prominent manufacturers of MEMS medical devices is the main factor supporting the growth of the market in this region. The growing healthcare awareness and the increasing prevalence of chronic diseases have stimulated the adoption rate of MEMS-based wearable devices. Market players in this region are investing heavily in the development of advanced self-monitoring devices such as pressure sensors. 1 out of every 4 deaths in the United States is due to a heart-related disorder. Near about 647,000 deaths occur due to heart disease, every year in the United States making it the leading cause of death. The growing prevalence of chronic diseases is fueling the growth of MEMS for the therapeutic market in this region.

The European region is forecasted to have the second-highest share of the MEMS for the therapeutic market. The merger and acquisitions were done by major companies, and the continuous R&D are the main factors promoting the development of the MEMS for the therapeutic market. Europe is also among the top regions that are heavily affected by chronic disorders. Moreover, the supportive government policies are further propelling the growth of the MEMS for the therapeutic market in this region.

The MEMS for the therapeutic market in the Asia-Pacific region is anticipated to develop at the highest CAGR attributed to the presence of the large semiconductors manufacturers in this region. Government and private organizations are collaborating to develop advanced MEMS for therapeutic usage. Huge investments in the Indian companies involved in the production of MEMS for healthcare services are providing a favorable condition for the expansion of the market in the Asia-Pacific region. Countries like India, China, and Japan are the prominent members contributing to the market's development.

Players Covered in MEMS For Therapeutic Market are:

• Honeywell (USA)
• Royal Philips (Netherlands)
• Texas Instruments (USA)
• STMicroelectronics (Netherlands)
• General Electric Company (USA)
• Debiotech (Switzerland)
• Agilent Technologies (USA)
• Omron Corporation (Japan)
• Silex Microsystems (Sweden)
• Sensera Ltd (Australia)

COVID-19 Impact on MEMS For Therapeutic Market

The outbreak of COVID-19 drastically affected the functioning of several industry verticals. The restrictions imposed on transportation created a shortage of materials required for the manufacturing of MEMS devices. COVID implications lowered R&D due to work from home that negatively affected progress for new technologies and products. In addition, a decrease in the government fundings affected the infrastructure development required for MEMS therapeutic market. Asian and European economies have suffered a major loss of business and revenue, due to the closure of manufacturing facilities in this region. Operations of the production and manufacturing industries have been heavily disrupted by the outbreak of the COVID-19 disease due to the unavailability of a workforce; thereby, hindering the growth of the MEMS for the therapeutic market in 2020. However, the market is expected to witness a recovery in its growth rate in coming years, owing to the growth in the focus of organizations to fulfill the surge in demand for smart technologies required in wearable devices. To summarize, in the post-pandemic the market is expected to bounce back attributed to the growing awareness of MEMS technologies in medical devices.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: MEMS For Therapeutic Market by Type
 5.1 MEMS For Therapeutic Market Overview Snapshot and Growth Engine
 5.2 MEMS For Therapeutic Market Overview
 5.3 Pressure
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Pressure: Grographic Segmentation
 5.4 Temperature
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Temperature: Grographic Segmentation
 5.5 Microfluidics
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Microfluidics: Grographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Grographic Segmentation

Chapter 6: MEMS For Therapeutic Market by Application
 6.1 MEMS For Therapeutic Market Overview Snapshot and Growth Engine
 6.2 MEMS For Therapeutic Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Grographic Segmentation
 6.4 Home Healthcare
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Home Healthcare: Grographic Segmentation
 6.5 Research Centers
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Research Centers: Grographic Segmentation
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Grographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 MEMS For Therapeutic Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 MEMS For Therapeutic Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 MEMS For Therapeutic Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 HONEYWELL
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 ROYAL PHILIPS
 7.4 TEXAS INSTRUMENTS
 7.5 STMICROELECTRONICS
 7.6 GENERAL ELECTRIC COMPANY
 7.7 DEBIOTECH
 7.8 AGILENT TECHNOLOGIES
 7.9 OMRON CORPORATION
 7.10 SILEX MICROSYSTEMS
 7.11 SENSERA LTD
 7.12 OTHER MAJOR PLAYERS

Chapter 8: Global MEMS For Therapeutic Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Pressure
  8.2.2 Temperature
  8.2.3 Microfluidics
  8.2.4 Others
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Hospitals
  8.3.2 Home Healthcare
  8.3.3 Research Centers
  8.3.4 Others

Chapter 9: North America MEMS For Therapeutic Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Pressure
  9.4.2 Temperature
  9.4.3 Microfluidics
  9.4.4 Others
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Hospitals
  9.5.2 Home Healthcare
  9.5.3 Research Centers
  9.5.4 Others
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe MEMS For Therapeutic Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Pressure
  10.4.2 Temperature
  10.4.3 Microfluidics
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Hospitals
  10.5.2 Home Healthcare
  10.5.3 Research Centers
  10.5.4 Others
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific MEMS For Therapeutic Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Pressure
  11.4.2 Temperature
  11.4.3 Microfluidics
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Hospitals
  11.5.2 Home Healthcare
  11.5.3 Research Centers
  11.5.4 Others
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa MEMS For Therapeutic Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Pressure
  12.4.2 Temperature
  12.4.3 Microfluidics
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Hospitals
  12.5.2 Home Healthcare
  12.5.3 Research Centers
  12.5.4 Others
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America MEMS For Therapeutic Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Pressure
  13.4.2 Temperature
  13.4.3 Microfluidics
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Hospitals
  13.5.2 Home Healthcare
  13.5.3 Research Centers
  13.5.4 Others
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. MEMS FOR THERAPEUTIC MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. MEMS FOR THERAPEUTIC MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. MEMS FOR THERAPEUTIC MARKET COMPETITIVE RIVALRY
TABLE 005. MEMS FOR THERAPEUTIC MARKET THREAT OF NEW ENTRANTS
TABLE 006. MEMS FOR THERAPEUTIC MARKET THREAT OF SUBSTITUTES
TABLE 007. MEMS FOR THERAPEUTIC MARKET BY TYPE
TABLE 008. PRESSURE MARKET OVERVIEW (2016-2028)
TABLE 009. TEMPERATURE MARKET OVERVIEW (2016-2028)
TABLE 010. MICROFLUIDICS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. MEMS FOR THERAPEUTIC MARKET BY APPLICATION
TABLE 013. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 014. HOME HEALTHCARE MARKET OVERVIEW (2016-2028)
TABLE 015. RESEARCH CENTERS MARKET OVERVIEW (2016-2028)
TABLE 016. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA MEMS FOR THERAPEUTIC MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA MEMS FOR THERAPEUTIC MARKET, BY APPLICATION (2016-2028)
TABLE 019. N MEMS FOR THERAPEUTIC MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE MEMS FOR THERAPEUTIC MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE MEMS FOR THERAPEUTIC MARKET, BY APPLICATION (2016-2028)
TABLE 022. MEMS FOR THERAPEUTIC MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC MEMS FOR THERAPEUTIC MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC MEMS FOR THERAPEUTIC MARKET, BY APPLICATION (2016-2028)
TABLE 025. MEMS FOR THERAPEUTIC MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA MEMS FOR THERAPEUTIC MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA MEMS FOR THERAPEUTIC MARKET, BY APPLICATION (2016-2028)
TABLE 028. MEMS FOR THERAPEUTIC MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA MEMS FOR THERAPEUTIC MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA MEMS FOR THERAPEUTIC MARKET, BY APPLICATION (2016-2028)
TABLE 031. MEMS FOR THERAPEUTIC MARKET, BY COUNTRY (2016-2028)
TABLE 032. HONEYWELL: SNAPSHOT
TABLE 033. HONEYWELL: BUSINESS PERFORMANCE
TABLE 034. HONEYWELL: PRODUCT PORTFOLIO
TABLE 035. HONEYWELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. ROYAL PHILIPS: SNAPSHOT
TABLE 036. ROYAL PHILIPS: BUSINESS PERFORMANCE
TABLE 037. ROYAL PHILIPS: PRODUCT PORTFOLIO
TABLE 038. ROYAL PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. TEXAS INSTRUMENTS: SNAPSHOT
TABLE 039. TEXAS INSTRUMENTS: BUSINESS PERFORMANCE
TABLE 040. TEXAS INSTRUMENTS: PRODUCT PORTFOLIO
TABLE 041. TEXAS INSTRUMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. STMICROELECTRONICS: SNAPSHOT
TABLE 042. STMICROELECTRONICS: BUSINESS PERFORMANCE
TABLE 043. STMICROELECTRONICS: PRODUCT PORTFOLIO
TABLE 044. STMICROELECTRONICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. GENERAL ELECTRIC COMPANY: SNAPSHOT
TABLE 045. GENERAL ELECTRIC COMPANY: BUSINESS PERFORMANCE
TABLE 046. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 047. GENERAL ELECTRIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. DEBIOTECH: SNAPSHOT
TABLE 048. DEBIOTECH: BUSINESS PERFORMANCE
TABLE 049. DEBIOTECH: PRODUCT PORTFOLIO
TABLE 050. DEBIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. AGILENT TECHNOLOGIES: SNAPSHOT
TABLE 051. AGILENT TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 052. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 053. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. OMRON CORPORATION: SNAPSHOT
TABLE 054. OMRON CORPORATION: BUSINESS PERFORMANCE
TABLE 055. OMRON CORPORATION: PRODUCT PORTFOLIO
TABLE 056. OMRON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. SILEX MICROSYSTEMS: SNAPSHOT
TABLE 057. SILEX MICROSYSTEMS: BUSINESS PERFORMANCE
TABLE 058. SILEX MICROSYSTEMS: PRODUCT PORTFOLIO
TABLE 059. SILEX MICROSYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. SENSERA LTD: SNAPSHOT
TABLE 060. SENSERA LTD: BUSINESS PERFORMANCE
TABLE 061. SENSERA LTD: PRODUCT PORTFOLIO
TABLE 062. SENSERA LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 063. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 064. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 065. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. MEMS FOR THERAPEUTIC MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. MEMS FOR THERAPEUTIC MARKET OVERVIEW BY TYPE
FIGURE 012. PRESSURE MARKET OVERVIEW (2016-2028)
FIGURE 013. TEMPERATURE MARKET OVERVIEW (2016-2028)
FIGURE 014. MICROFLUIDICS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. MEMS FOR THERAPEUTIC MARKET OVERVIEW BY APPLICATION
FIGURE 017. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 018. HOME HEALTHCARE MARKET OVERVIEW (2016-2028)
FIGURE 019. RESEARCH CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA MEMS FOR THERAPEUTIC MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE MEMS FOR THERAPEUTIC MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC MEMS FOR THERAPEUTIC MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA MEMS FOR THERAPEUTIC MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA MEMS FOR THERAPEUTIC MARKET OVERVIEW BY COUNTRY (2016-2028)